The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line. (Record no. 27476989)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02016 a2200553 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517170923.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201809s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1568-5608 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s10787-017-0386-4 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Jafarnezhad-Ansariha, Fahimeh |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180905 |
245 00 - TITLE STATEMENT | |
Title | The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Inflammopharmacology |
Date of publication, distribution, etc. | Apr 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 375-384 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Inflammatory Agents, Non-Steroidal |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclooxygenase 1 |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclooxygenase 2 |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hexuronic Acids |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunosuppressive Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Inflammation |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Iran |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Macrophages |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Monocytes |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Spondylitis, Ankylosing |
General subdivision | drug therapy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yekaninejad, Mir Saeed |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jamshidi, Ahmad-Reza |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mansouri, Reza |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vojdanian, Mahdi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mahmoudi, Mahdi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fattahi, Mohammad Javad |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hashemi, Seyed Naser |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rehm, Bernd H A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Matsuo, Hidenori |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Esposito, Emanuela |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cuzzocrea, Salvatore |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mirshafiey, Abbas |
773 0# - HOST ITEM ENTRY | |
Title | Inflammopharmacology |
Related parts | vol. 26 |
-- | no. 2 |
-- | p. 375-384 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s10787-017-0386-4">https://doi.org/10.1007/s10787-017-0386-4</a> |
Public note | Available from publisher's website |
No items available.